Presentation is loading. Please wait.

Presentation is loading. Please wait.

Analysis of the Human Ferrochelatase Promoter in Transgenic Mice

Similar presentations


Presentation on theme: "Analysis of the Human Ferrochelatase Promoter in Transgenic Mice"— Presentation transcript:

1 Analysis of the Human Ferrochelatase Promoter in Transgenic Mice
by Scott T. Magness, Antonio Tugores, Edward S. Diala, and David A. Brenner Blood Volume 92(1): July 1, 1998 ©1998 by American Society of Hematology

2 Reporter gene constructs used to generate transgenic mouse lines.
Reporter gene constructs used to generate transgenic mouse lines. The structure of the constructs used to generate the −0.15 TG and −4.0 TG lines are shown. Construct −0.15 TG contains the minimal human ferrochelatase promoter containing two Sp1-like elements, and construct −4.0 TG contains the minimal promoter, the erythroid enhancer elements GATA, and NF-E2 and approximately 3.5 kb of upstream sequence. Both promoter constructs drive the expression of the luciferase reporter gene. Scott T. Magness et al. Blood 1998;92: ©1998 by American Society of Hematology

3 Whole mount in situ hybridization detects ferrochelatase and luciferase expression in −4.0 TG mouse embryos. Whole mount in situ hybridization detects ferrochelatase and luciferase expression in −4.0 TG mouse embryos. Whole-mount in situ hybridization was performed on 15.5 d.p.c. embryos by using antisense DIG-labeled RNA probes. (A) Detection of the luciferase transgene in the fetal liver of luciferase positive (left) and luciferase negative (right) transgenic litter mates. Transversal sections are shown, and the view is from posterior to anterior. (B) and (C) indicate staining in the gonads (left and right arose from different transversal microtome sections) of the luciferase positive mouse shown in (A). (D) Shows the localization of the endogenous murine ferrochelatase gene to the fetal liver at the same developmental stage. In all cases, hybridization to sense RNA probes gave no detectable signal (not shown). Scott T. Magness et al. Blood 1998;92: ©1998 by American Society of Hematology

4 Scott T. Magness et al. Blood 1998;92:320-328
©1998 by American Society of Hematology

5 Scott T. Magness et al. Blood 1998;92:320-328
©1998 by American Society of Hematology

6 Cellular expression of the luciferase reporter gene in the spleen.
Cellular expression of the luciferase reporter gene in the spleen. Sections of spleen from control-treated or PHZ-treated −4.0 TG mice were (A) stained with hematoxylin/eosin to assess cell lineage or (B) probed for luciferase expression with an antisense DIG-labeled luciferase RNA probe and counterstained with eosin. Lymphatic nodules are noted with a white arrow (A and B) and erythroid precursor cell clusters are noted with a black arrow (A and B, PHZ+). Hybridization to sense RNA probes gave no detectable signal (not shown). Scott T. Magness et al. Blood 1998;92: ©1998 by American Society of Hematology

7 Luciferase activities in −0. 15 TG and −4
Luciferase activities in −0.15 TG and −4.0 TG mice suggest elements 5′ of the proximal promoter are necessary for enhanced erythroid expression. Luciferase activities in −0.15 TG and −4.0 TG mice suggest elements 5′ of the proximal promoter are necessary for enhanced erythroid expression. Mice containing the −0.15 TG and −4.0 TG constructs were treated with a 7-day regimen of PBS (PHZ-, hatched bars) or PHZ (solid bars). On day 9, fragments of liver or spleen were homogenized in luciferase assay buffer and luciferase activity was assessed as described previously. Letters below each set of bars represent individual founder mice. Each bar represents an average luciferase activity of two to three mice from each founder. Three scales are necessary to accurately display the range of data obtained for the two transgenic lines. Scott T. Magness et al. Blood 1998;92: ©1998 by American Society of Hematology

8 A unique HS site appears 5′ of the proximal promoter in PHZ-treated −4
A unique HS site appears 5′ of the proximal promoter in PHZ-treated −4.0 TG mouse spleen nuclei. A unique HS site appears 5′ of the proximal promoter in PHZ-treated −4.0 TG mouse spleen nuclei. (A) Location of the probe used for the detection of DNase I HS sites is indicated (dark hatched box) in the context of both the human ferrochelatase genomic locus (top) and the luciferase reporter transgene (bottom). The black box represents exon 1, open boxes represent SV40 sequences, and the light hatched box represents the luciferase reporter gene from p19 Luc (B, BamHI; P, PstI; and Xb, Xba I). (B) Nuclei were isolated from both normal and PHZ-treated spleens from −4.0 TG mice. After DNase I digestion of intact nuclei, DNA was isolated, digested to completion withBamHI, and the resulting fragments were identified by using the indicated probe in Southern blot analysis. The resulting fragments and their sizes are indicated. (C) Location of putativecis-elements as deduced from the analysis of the primary structure of the hypersensitive region and surrounding sequences (top). The open box (at −2.05 kb to −2.2 kb) indicates the AT-rich region. The location of this HS region and surrounding sequences within the transgene is indicated (bottom). Scott T. Magness et al. Blood 1998;92: ©1998 by American Society of Hematology


Download ppt "Analysis of the Human Ferrochelatase Promoter in Transgenic Mice"

Similar presentations


Ads by Google